Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Nasus Pharma Ltd (NSRX)

Nasus Pharma Ltd (NSRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Intranasal therapies by asadykov via Shutterstock
Nasus Pharma's NS002 Outperformed EpiPen® in Phase 2. Has the Market Caught Up? Barchart Impact - Tue Apr 28, 10:04AM CDT

Nasus Pharma (NSRX) is advancing a statistically superior, needle-free intranasal epinephrine powder toward a pivotal Q4 2026 study, backed by Phase 2 data that beat the EpiPen’s speed-to-thr

NSRX : 2.87 (+4.74%)
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms ACCESS Newswire - Tue Apr 7, 6:00AM CDT

ORLANDO, FL / ACCESS Newswire / April 7, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming virtual...

CLDI : 0.1900 (+12.23%)
INAB : 1.6800 (+7.01%)
CNTB : 2.36 (+2.16%)
DMAC : 5.77 (+0.87%)
NSRX : 2.87 (+4.74%)
The Hidden Engine Behind Billion-Dollar Pharma Deals - And Why Nasus Pharma May Be Building One of Its Own Chainwire - Mon Nov 24, 2025

WSW, NY, 24th November 2025, FinanceWire … Read More

NVO : 44.39 (-1.51%)
LLY : 1,041.65 (+2.24%)
NSRX : 2.87 (+4.74%)
Nasus Pharma Expands Collaboration with Aptar for Intranasal Epinephrine Program Tipranks - Thu Oct 9, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

NSRX : 2.87 (+4.74%)

Barchart Exclusives

The Path to 'Peak' Nvidia: Why the AI Giant's Future Will Inevitably Include Stiff Competition Barchart - Thu May 21, 3:25PM CDT
Nvidia sits at the absolute peak of its operational power, shielded by its massive CUDA moat, but the macroeconomic and competitive tides are turning. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.